In this complimentary report, PharmAsia News takes a closer look at R&D strategies in Asia, focusing on India, China and Korea. In India, Sanofi-Aventis's media-shy leader Shailesh Ayyangar sits down with PharmAsia News in a rare interview to discuss Sanofi's strategy in rural markets.
In China, PPD's Lee Babbis, Roche's former head of research, talks with PharmAsia News about the evolving relationships between biopharma firms and CROs, including end-to-end virtualization of R&D.
And in Korea, PharmAsia News Bureau Chief Peter Chang reports from Seoul about government efforts to establish an R&D fund to help local companies develop innovative new drugs.
CLICK HERE to access this complimentary report
